CoChat
Cited by 187

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging

Schmidkonz, Christian, Rauber, Simon, Atzinger, Armin, Agarwal, Rahul, Götz, Theresa Ida, Soare, Alina, Cordes, Michael, Prante, Olaf, Bergmann, Christina, Kleyer, Arnd, Ritt, Philipp, Maschauer, Simone, Hennig, Peter, Toms, Johannes, Köhner, Markus, Manger, Bernhard, Stone, John H, Haberkorn, Uwe, Baeuerle, Tobias, Distler, Jörg H W, Agaimy, Abbas, Kuwert, Torsten, Schett, Georg, Ramming, Andreas · 2020 · Annals of the Rheumatic Diseases

Abstract

Objectives To date, there is no valuable tool to assess fibrotic disease activity in humans in vivo in a non-invasive way. This study aims to uncouple inflammatory from fibrotic disease activity in fibroinflammatory diseases such as IgG4-related disease. Methods In this cross-sectional clinical study, 27 patients with inflammatory, fibrotic and overlapping manifestations of IgG4-related disease underwent positron emission tomography (PET) scanning with tracers specific for fibroblast activation protein (FAP; 68Ga-FAP inhibitor (FAPI)-04), 18F-fluorodeoxyglucose (FDG), MRI and histopathological assessment. In a longitudinal approach, 18F-FDG and 68Ga-FAPI-04 PET/CT data were evaluated before and after immunosuppressive treatment and correlated to clinical and MRI data. Results Using combination of 68Ga-FAPI-04 and 18F-FDG-PET, we demonstrate that non-invasive functional tracking of IgG4-related disease evolution from inflammatory towards a fibrotic outcome becomes feasible. 18F-FDG-PET positive lesions showed dense lymphoplasmacytic infiltration of IgG4 + cells in histology, while 68Ga-FAPI-04 PET positive lesions showed abundant activated fibroblasts expressing FAP according to results from RNA-sequencing of activated fibroblasts. The responsiveness of fibrotic lesions to anti-inflammatory treatment was far less pronounced than that of inflammatory lesions. Conclusion FAP-specific PET/CT permits the discrimination between inflammatory and fibrotic activity in IgG4-related disease. This finding may profoundly change the management of certain forms of immune-mediated disease, such as IgG4-related disease, as subtypes dominated by fibrosis may require different approaches to control disease progression, for example, specific antifibrotic agents rather than broad spectrum anti-inflammatory treatments such as glucocorticoids.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2020-217408

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 187

Metadata

Authors
Schmidkonz, C., Rauber, S., Atzinger, A., Agarwal, R., Götz, T. I., Soare, A., Cordes, M., Prante, O., Bergmann, C., Kleyer, A., Ritt, P., Maschauer, S., Hennig, P., Toms, J., Köhner, M., Manger, B., Stone, J. H., Haberkorn, U., Baeuerle, T., Distler, J. H. W., Agaimy, A., Kuwert, T., Schett, G., & Ramming, A.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2020-11
Volume
79
Issue
11
Pages
1485-1491
ISSN
0003-4967 (ISSN-L)
OpenAlex
W3044392771
Cited by
187
References
8
FWCI
16.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. https://app.cochat.ai/papers/10.1136/annrheumdis-2020-217408
The paper
Schmidkonz, C., Rauber, S., Atzinger, A., Agarwal, R., Götz, T. I., Soare, A., Cordes, M., Prante, O., Bergmann, C., Kleyer, A., Ritt, P., Maschauer, S., Hennig, P., Toms, J., Köhner, M., Manger, B., Stone, J. H., Haberkorn, U., Baeuerle, T., . . . Ramming, A. (2020). Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217408

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.